Our Science – Dunleavy Website
Kieron M. Dunleavy, M.D.
Selected Publications |
 |
| 1)
Dunleavy K, Kohler DR, Wilson WH. Non Hodgkin Lymphoma. In: Hematology-Oncology Therapy. Volume 1. New York: McGraw Hill; 2007. p. 308-346 [Book Chapter] |
|
| 2)
Healey-Bird B, Dunleavy K, White T, Wilson WH, Wiestner A. A Patient With Stage IV Mantle Cell Lymphoma Treated With Bortezomib/DA-EPOCH/Rituximab. Case Studies in Lymphoma. 5: No.2, 2007. Full Text Article. [Journal] |
|
| 3)
Dunleavy K, Wilson WH, Jaffe ES. Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications. Curr. Opin. Hematol. 14: 348-53, 2007. [Journal] |
|
| 4)
Dunleavy K, Wilson WH. Angioimmunoblastic T-cell lymphoma: immune modulation as a therapeutic strategy. Leuk. Lymphoma. 48: 449-51, 2007. [Journal] |
|
| 5)
Dunleavy K, Davis RE, Landgren O, Staudt LM, Wilson WH. BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?. Blood. 109: 843-4; discussion 844-5, 2007. [Journal] |
|
| 6)
Dunleavy K, Staudt LM, Wilson WH. The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma. Leuk. Lymphoma. 48: 1061-3, 2007. [Journal] |
|
| 7)
Dunleavy K, Wilson W. Malignant Lymphomas. In: American College of Physicians Medicine Textbook. Volume 2. New York: WebMD; 2006. p. 2591-2608 [Book Chapter] |
|
| 8)
Dunleavy K, Kass E, Gill R, Wilson WH. Lymphomas of the Head and Neck. Emedicine. Otolaryngology and Facial Plastic Surgery. ., 2006. Full Text Article. [Journal] |
|
| 9)
Dunleavy K, Wilson WH. Primary intraocular lymphoma: current and future perspectives. Leuk. Lymphoma. 47: 1726-7, 2006. [Journal] |
|
| 10)
Dunleavy K, Wilson WH, Kaplan LD. The case for rituximab in AIDS-related lymphoma. Blood. 107: 3014-5, 2006. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 1/8/2008.
